| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |